---
document_datetime: 2023-09-21 17:24:12
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/alkindi-epar-all-authorised-presentations_en.pdf
document_name: alkindi-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.8907824
conversion_datetime: 2025-12-24 02:19:58.684705
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| EU (MA) Number   | (Invented) name   | Strength   | Pharmaceutical Form              | Route of Administration   | Immediate Packaging   | Pack size   |
|------------------|-------------------|------------|----------------------------------|---------------------------|-----------------------|-------------|
| EU/1/17/1260/001 | Alkindi           | 0.5 mg     | Granules in capsules for opening | Oral use                  | bottle (HDPE)         | 50 capsules |
| EU/1/17/1260/002 | Alkindi           | 1.0 mg     | Granules in capsules for opening | Oral use                  | bottle (HDPE)         | 50 capsules |
| EU/1/17/1260/003 | Alkindi           | 2.0 mg     | Granules in capsules for opening | Oral use                  | bottle (HDPE)         | 50 capsules |
| EU/1/17/1260/004 | Alkindi           | 5.0 mg     | Granules in capsules for opening | Oral use                  | bottle (HDPE)         | 50 capsules |